Maintaining cell health and viability in cell processing
On demand

Maintaining cell health and viability in cell processing

Thursday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Maintaining cell health and viability in cell processing

Cell separation is essential to cell therapy clinical manufacturing workflows. Maintenance of cell health and viability is key in steps where cell separation is performed such as washing cells, concentrating cells, and/or performing buffer exchange.

Counterflow centrifugation (CFC) can be an ideal technique for cell therapy applications. It is a low-shear stress technique that is inherently gentle to cells, enabling cell health and viability.

In this webinar you’ll learn about CFC and selected applications of it in cell therapy workflows:      

  • For PBMC separation for T and NK cell processing
  • In CAR T cell manufacturing
  • For whole blood processing
  • Closed-system harvesting and processing iPSCs and MSCs
Josh Judkins
Josh Judkins
Business Development Manager, Cell & Gene Therapy at Thermo Fisher Scientific

Josh earned his BS in Biochemistry from Ohio Northern University, and MS and PhD in Chemistry and Chemical Biology at Cornell University. After graduate school, Josh completed a postdoc in Neuroscience Chemical Biology at Pfizer in Cambridge, Massachusetts (MA), and has been active in the biotech community since then. After Pfizer, Josh joined Thermo Fisher Scientific, where he has been for over 7 years holding various life science-focused technical roles and is currently the Eastern MA Cell & Gene Therapy Business Development Manager.